Gene packaging tells story of cancer development

Dec 04, 2008

To decipher how cancer develops, Johns Hopkins Kimmel Cancer Center investigators say researchers must take a closer look at the packaging.

Specifically, their findings in the December 2, 2008, issue of PLoS Biology point to the three dimensional chromatin packaging around genes formed by tight, rosette-like loops of Polycomb group proteins (PcG). The chromatin packaging, a complex combination of DNA and proteins that compress DNA to fit inside cells, provides a repressive hub that keeps genes in a low expression state.

"We think the polycomb proteins combine with abnormal DNA methylation of genes to deactivate tumor suppressor genes and lock cancer cells in a primitive state," says Stephen B. Baylin, M.D., Virginia and D.K. Ludwig Professor of Oncology and senior author.

Prior to this discovery, investigators studying cancer genes, looked at gene silencing as a linear process across the DNA, as if genes were flat, one dimensional objects. Research did not take into account the way genes are packaged.

To better understand the role of the PcG packaging, the team compared embryonic cells to adult colon cancer cells. The gene studied in the embryonic cells was packaged by PcG proteins, in a low expression state, and had no DNA methylation. When the gene received signals for cells to mature, the PcG loops were disrupted and the gene was highly expressed. However, when the same gene was abnormally DNA methylated, as is the case in adult, mature colon cancer cells, the PcG packaging loops were tighter and there was no gene expression. "These tight loops touch and interact with many gene sites folding it into a structure that shuts off tumor suppressor genes," says Baylin. However, when the researchers removed DNA methylation from the cancer cells, the loops loosened somewhat, back to the state of an embryonic cell, and some gene expression was restored.

DNA methylation is a normal cellular process, but when it goes awry and genes are improperly methylated, it can shut down important tumor suppressing cell functions.

Demethylating agents, drugs that target and remove abnormal DNA methylation from genes, have been introduced as potential new cancer therapies. For these therapies to be fully effective, Baylin says, researchers may also need to look for agents that disrupt PcG loops.

Source: Johns Hopkins Medical Institutions

Explore further: Decades-old amber collection offers new views of a lost world (w/ Video)

add to favorites email to friend print save as pdf

Related Stories

Fires in the Northern Territories July 2014

42 minutes ago

Environment Canada has issued a high health risk warning for Yellowknife and surrounding area because of heavy smoke in the region due to forest fires. In the image taken by the Aqua satellite, the smoke ...

The birth of topological spintronics

58 minutes ago

The discovery of a new material combination that could lead to a more efficient approach to computer memory and logic will be described in the journal Nature on July 24, 2014. The research, led by Penn S ...

Recommended for you

Sugar mimics guide stem cells toward neural fate

1 hour ago

Embryonic stem cells can develop into a multitude of cells types. Researchers would like to understand how to channel that development into the specific types of mature cells that make up the organs and other structures of ...

Chinese mosquitos on the Baltic Sea

1 hour ago

The analysis of the roughly 3,000 pieces is still in its infant stage. But it is already evident that the results will be of major significance. "Amazingly often, we are finding–in addition to Asian forms–the ...

Baby zebra is latest success in research partnership

2 hours ago

The recent birth of a female Grevy's zebra foal at the Saint Louis Zoo marks another milestone in a long-running Washington University in St. Louis research partnership that is making significant contributions ...

User comments : 0